IRadimed has received 510(k) clearance from the FDA for MRidium 3860+MRI infusion system. The device, which features Masimo Set SpO2 monitoring, allows patients to get MRI screening while undergoing infusion treatment.
Published in Brief:
|Chief Operating Officer||
Presence Health Partners
|Des Plaines, IL|
|Sr. Business Systems Analyst||
|Sr. Reimbursement Analyst||
Olympus America Inc.
|Staff VP Medical Policy Development-81321||
|Strategic Partner Relationship Executive||
Geisinger Health System